| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Given Douglas B is a Director at ARROWHEAD PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $9.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 5,547 | $21.91 | $121,555.88 | -2.2% | -30.0% | +191.0% | |
| Jan 11, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 2,911 | $38.06 | $110,788.36 | -1.1% | -32.3% | -50.7% | |
| May 5, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 6,500 | $40.90 | $265,850.00 | -5.2% | -21.9% | -40.9% | |
| Feb 27, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 875 | $32.62 | $28,542.50 | -6.3% | +0.6% | -4.4% | |
| Dec 28, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Buy | 655 | $66.37 | $43,472.35 | +0.6% | -32.2% | -43.1% | |
| Sep 9, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 5,000 | $65.24 | $326,200.00 | -4.4% | +13.3% | -40.9% | |
| Jun 22, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 4,500 | $89.21 | $401,445.00 | -3.8% | -29.8% | -64.5% | |
| Feb 22, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 1,125 | $88.73 | $99,821.25 | -7.5% | -12.0% | -49.3% | |
| Jan 15, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 3,000 | $83.28 | $249,840.00 | -19.4% | - | - | |
| Jan 4, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 4,000 | $76.08 | $304,320.00 | -3.2% | - | - |